鲁抗医药：2025年年度业绩预告

Core Viewpoint - The company, LuKang Pharmaceutical, anticipates a significant decline in net profit for the year 2025, projecting a decrease of 24.96 million to 28.46 million yuan compared to the previous year, which translates to a year-on-year reduction of 63.26% to 72.13% [1] Financial Performance - The expected net profit for 2025 is estimated to be between 110 million yuan and 145 million yuan [1] - This represents a substantial decrease from the previous year's figures, indicating potential challenges in the company's financial performance [1]